Literature DB >> 25200262

Brain MRI of children with retinopathy-negative cerebral malaria.

Douglas G Postels1, Chenxi Li2, Gretchen L Birbeck2, Terrie E Taylor2, Karl B Seydel2, Sam D Kampondeni2, Simon J Glover2, Michael J Potchen2.   

Abstract

Our goals were to understand the brain magnetic resonance imaging (MRI) findings in children with retinopathy-negative cerebral malaria (CM) and investigate whether any findings on acute MRI were associated with adverse outcomes. We performed MRI scans on children admitted to the hospital in Blantyre, Malawi with clinically defined CM. Two hundred and seventeen children were imaged during the study period; 44 patients were malarial retinopathy-negative; and 173 patients were retinopathy-positive. We compared MRI findings in children with retinopathy-negative and retinopathy-positive CM. In children who were retinopathy-negative, we identified MRI variables that were associated with death and adverse neurologic outcomes. On multivariate analysis, cortical diffusion weighted imaging (DWI) abnormality and increased brain volume were strongly associated with neurologic morbidity in survivors. Investigations to explore the underlying pathophysiologic processes responsible for these MRI changes are warranted. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2014        PMID: 25200262      PMCID: PMC4228891          DOI: 10.4269/ajtmh.14-0216

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  25 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

Review 2.  Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review.

Authors:  Jun-ichi Takanashi; A James Barkovich; Ken-ichi Yamaguchi; Yoichi Kohno
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

3.  Malarial retinopathy in cerebral malaria.

Authors:  Nicholas A V Beare; Simon J Glover; Malcolm Molyneux
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

4.  Retinal haemorrhage in children with malaria.

Authors:  S Lewallen; B A Wills
Journal:  Lancet       Date:  1993-02-13       Impact factor: 79.321

5.  Identification of malaria retinopathy improves the specificity of the clinical diagnosis of cerebral malaria: findings from a prospective cohort study.

Authors:  Gretchen L Birbeck; Nicholas Beare; Susan Lewallen; Simon J Glover; Malcolm E Molyneux; Peter W Kaplan; Terrie E Taylor
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

6.  Reversible focal splenium lesion--MRS study of a different etiology.

Authors:  Yu-Wei Lin; Chin-Yin Yu
Journal:  Acta Neurol Taiwan       Date:  2009-09

Review 7.  Advances in pediatric neurovirology.

Authors:  John R Crawford
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

8.  Using malarial retinopathy to improve the classification of children with cerebral malaria.

Authors:  Susan Lewallen; Rachel N Bronzan; Nicholas A Beare; Simon P Harding; Malcolm E Molyneux; Terrie E Taylor
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-08-28       Impact factor: 2.184

9.  Caring for children with cerebral malaria: insights gleaned from 20 years on a research ward in Malawi.

Authors:  Terrie E Taylor
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-01-06       Impact factor: 2.184

10.  Differentiating the pathologies of cerebral malaria by postmortem parasite counts.

Authors:  Terrie E Taylor; Wenjiang J Fu; Richard A Carr; Richard O Whitten; Jeffrey S Mueller; Nedson G Fosiko; Susan Lewallen; N George Liomba; Malcolm E Molyneux; Jeffrey G Mueller
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

View more
  7 in total

1.  MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice.

Authors:  Brittany A Riggle; Sanhita Sinharay; William Schreiber-Stainthorp; Jeeva P Munasinghe; Dragan Maric; Eva Prchalova; Barbara S Slusher; Jonathan D Powell; Louis H Miller; Susan K Pierce; Dima A Hammoud
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

2.  Diffusion-Weighted MR Imaging in a Prospective Cohort of Children with Cerebral Malaria Offers Insights into Pathophysiology and Prognosis.

Authors:  S M Moghaddam; G L Birbeck; T E Taylor; K B Seydel; S D Kampondeni; M J Potchen
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-22       Impact factor: 3.825

3.  Theta-Alpha Variability on Admission EEG Is Associated With Outcome in Pediatric Cerebral Malaria.

Authors:  Alexander Andrews; Tesfaye Zelleke; Dana Harrar; Rima Izem; Jiaxiang Gai; Douglas Postels
Journal:  J Clin Neurophysiol       Date:  2021-05-27       Impact factor: 2.177

Review 4.  Desperately Seeking Therapies for Cerebral Malaria.

Authors:  Brittany A Riggle; Louis H Miller; Susan K Pierce
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

Review 5.  Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries.

Authors:  Gagandeep Singh; Samuel A Angwafor; Alfred K Njamnshi; Henry Fraimow; Josemir W Sander
Journal:  Nat Rev Neurol       Date:  2020-05-19       Impact factor: 42.937

6.  A retinal model of cerebral malaria.

Authors:  François Paquet-Durand; Susanne C Beck; Soumyaparna Das; Gesine Huber; Timm Schubert; Naoyuki Tanimoto; Marina Garcia-Garrido; Regine Mühlfriedel; Sylvia Bolz; Wolfgang Hoffmann; Ulrich Schraermeyer; Benjamin Mordmüller; Mathias W Seeliger
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

7.  Aggressive antipyretics in central nervous system malaria: Study protocol of a randomized-controlled trial assessing antipyretic efficacy and parasite clearance effects (Malaria FEVER study).

Authors:  Moses B Chilombe; Michael P McDermott; Karl B Seydel; Manoj Mathews; Musaku Mwenechanya; Gretchen L Birbeck
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.